Pancreatic Cancer Research

ResearcherHarvard UniversityNo recent work listed

João Incio

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0259-1356; OpenAlex author ID A5028060907. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 1 paper

Papers 3

  1. Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-17-0256↗
  2. Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy. Co-author DOI 10.1158/2159-8290.cd-15-1177↗
  3. Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages. Co-author DOI 10.1371/journal.pone.0141392↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rakesh K. Jain · 3 shared papers, 2015–2017 · strength 0.14
  2. Hao Liu · 3 shared papers, 2015–2017 · strength 0.14
  3. Vikram Deshpande · 2 shared papers, 2015–2017 · strength 0.10
  4. Yves Boucher · 2 shared papers, 2016–2017 · strength 0.09
  5. Theodoros P. Michelakos · 2 shared papers, 2016–2017 · strength 0.09
  6. Cristina Rosa Ferrone · 2 shared papers, 2016–2017 · strength 0.09
  7. Dai Fukumura · 2 shared papers, 2015–2016 · strength 0.09
  8. Theodore Sunki Hong · 1 shared paper, 2017 · strength 0.05
  9. Janet E. Murphy · 1 shared paper, 2017 · strength 0.05
  10. Carlos Fernández-del Castillo · 1 shared paper, 2017 · strength 0.05
  11. David P. Ryan · 1 shared paper, 2017 · strength 0.05
  12. Keith D. Lillemoe · 1 shared paper, 2017 · strength 0.05
  13. Ronald M. Evans · 1 shared paper, 2017 · strength 0.05
  14. Keehoon Jung · 1 shared paper, 2016 · strength 0.04
  15. Nuh N. Rahbari · 1 shared paper, 2016 · strength 0.04
  16. Jelena Grahovac · 1 shared paper, 2016 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.